An open-label, randomized, single-dose, two-way crossover bioequivalence study is designed to determine whether single oral dose of IMP4297 capsules 100 mg (5 × 20 mg strength) and IMP4297 capsules 100 mg (10 × 10 mg strength) are bioequivalent in healthy Chinese male subjects under fed condition.~36 subjects (at least 30 completed) are planned to be enrolled.
An open-label, randomized, single-dose, two-way crossover bioequivalence study to compare two strengths (10 mg and 20 mg) of IMP4297 capsules in healthy Chinese subjects under fed condition